The Black Swan Research Initiative® Is the “Myeloma Moonshot”

Vice President Joe Biden’s cancer “moonshot” has been very much in the news since it was made widely public in President Barack Obama’s State of the Union speech earlier this month. Most commentary has been positive – who does not want more money to go for cancer research? Apparently, the National Cancer Institute’s budget will be increased by $260.5 million to a total of $5.21 billion in the recently approved fiscal 2016 budget.

Black Swan Research Initiative® Update

The Black Swan Research Initiative® (BSRI) is on the brink of several key steps forward, I am happy to report.  Great progress has already been made.

What Causes Myeloma? New Study Suggests Random Mutations Are Important

A new study published in Science magazine and reported in the New York Times this week shows that random mutations in normal tissues are more important than previously thought. The study, conducted by Johns Hopkins Medicine researchers Cristian Tomasetti and Bert Vogelstein, did not analyze myeloma, but developed principles that apply broadly for all cancers.

Diagnosing Myeloma Early: New IMWG Guidelines

For some time, members of theInternational Myeloma Working Group (IMWG), the IMF's research division, have been trying to identify and describe a group of patients without 

Frontline Therapy and MRD: Exciting New Data from France

A recent study illustrates just how useful minimal residual disease (MRD) testing by flow cytometry is to predict excellent outcomes with new highly active combination therapies.

Pages